Zantac
In October 2019, a class-action lawsuit was filed against Sanofi for allegedly misleadingly marketing the over-the-counter heartburn medication Zantac as safe when, according to plaintiffs, the medicine contains dangerously high levels of the carcinogen N-nitrosodimethylamine (NDMA). (Rodriguez et al v. Sanofi U.S. LLC et al, Case No. 19-cv-9527, S. D. NY.)
Class-Action Tracker
The Latest
Worst False Ad Settlements of 2023
Class-action settlements that left consumers behind this year.
Todd Snyder
“Sitewide” sale didn’t include all items for sale on the site.
Roblox Marketers Feel The Tension—Inside Brands’ Next Challenge On The Platform
Asa Hiken, Adage
Why is Walmart’s 13+ Roblox Game Displaying a COPPA Seal?
Only users who are 13 and older can enter Walmart Discovered.
ESPN BET’s $1,000 Deposit Match
Here’s how much you need to deposit – and wager – in order to get $1,000 of real money.